Internal Medicine, Critical Care Medicine · Philadelphia, PA
NPI
1821167941
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3400 Civic Center Blvd, West Pavilion-1st Floor-Suite 1-600 W
Philadelphia, PA, 19104
Phone (215) 662-3202
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
857 services
Medicare patients, 2024
180
Average age 66
Drug cost, 2024
$9.3M
2,088 prescriptions
Company payments, 2025
$18K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kerri A Smith was code 99215 (office e&m - established), 213 times for 103 patients. In total Kerri A Smith billed 857 services in 22 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 213 | 103 | $108.15 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 153 | 100 | $12.63 | $1,933 |
| 93010 Electrocardiogram | Facility | 145 | 94 | $6.24 | $905 |
| 99291 Critical Care E&M | Facility | 108 | 31 | $171.65 | $19K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 58 | 42 | $24.26 | $1,407 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 40 | 22 | $12.96 | $519 |
| 99205 Office E&M - New | Facility | 28 | 28 | $147.03 | $4,117 |
| 93451 Percutaneous Transcatheterization | Facility | 25 | 25 | $104.20 | $2,605 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 12 | $95.86 | $2,013 |
| 99214 Office E&M - Established | Facility | 12 | 11 | $77.93 | $935 |
By year: 2022 $70K for 720 services; 2023 $59K for 678 services; 2024 $61K for 857 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kerri A Smith prescribed most often to Medicare patients was Tadalafil, with 303 prescriptions and refills. In total Kerri A Smith wrote 2,088 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tadalafil Generic | 303 | 331 | 38 | $241K |
| Opsumit Macitentan | 278 | 280 | 35 | $3.6M |
| Ambrisentan Generic | 151 | 151 | 19 | $496K |
| Sildenafil Citrate Generic | 114 | 182 | 29 | $41K |
| Furosemide Generic | 109 | 263 | 37 | $823 |
| Bumetanide Generic | 85 | 161 | 18 | $6,882 |
| Uptravi Selexipag | 77 | 77 | Under 11 | $1.8M |
| Spironolactone Generic | 65 | 179 | 20 | $1,144 |
| Adempas Riociguat | 63 | 63 | Under 11 | $858K |
| Letairis Ambrisentan | 51 | 51 | Under 11 | $631K |
| Potassium Chloride Generic | 48 | 93 | 15 | $1,366 |
| Adcirca Tadalafil | 42 | 44 | Under 11 | $177K |
| Prednisone Generic | 40 | 62 | 16 | $193 |
| Gabapentin Generic | 32 | 33 | Under 11 | $370 |
| Winrevair Sotatercept-Csrk | 29 | 29 | Under 11 | $416K |
Brand drugs: - claims; generic drugs: 1,310 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kerri A Smith $18K ($18K in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.